Related Experiment Video
Updated: Sep 20, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Myc manipulates the miRNA content and biologic functions of small cell lung cancer cell-derived small extracellular
Onur Tokgün1,2, Kubilay İnci3
1Medical Genetics, Faculty of Medicine, Pamukkale University, Denizli, Turkey. onur_tokgun@hotmail.com.
Background:
MYC genes are amplified/overexpressed in 20% of SCLCs, showing that Myc and Myc-dependent cellular mechanisms are strong candidates as therapeutic targets in SCLC. Small extracellular vesicles support the carcinogenesis process by acting as messengers delivering nucleic acids and proteins-moreover, no reports associate Myc and the functional effect of small extracellular vesicles in small cell lung cancer.
Methods And Results:
After the effects of small extracellular vesicles (sEVs) obtained from H82 and H209 cells on HUVEC and MRC-5 cells were observed, the Myc-dependent effect of the sEVs on oncogenic potentials was further evaluated by manipulating Myc expression via lentiviral vectors in H82 and H209 cells. Then, small extracellular vesicles of Myc-manipulated SCLC cells were isolated using sEVs isolation reagents. Finally, HUVEC and MRC5 cells were treated with SCLC-derived small extracellular vesicles. Cellular activity of recipient normal lung cells was investigated by cell growth assay, wound healing assay, and transwell assay. miRNA composition changes in small extracellular vesicles and SCLC cells were investigated using miRNA microarray and QRT-PCR assay. Our results indicated that normal lung cells treated with SCLC-derived small extracellular vesicles had higher proliferation, migration capability than non-treated counterparts. Additionally, after investigating the potential effects of small extracellular vesicles derived from Myc-dysregulated SCLC cell lines, we further evaluated the Myc-dependent miRNA composition in the small extracellular vesicles. The present study revealed that Myc regulates hsa-miR-7, hsa-miR-9, hsa-miR-125b, hsa-miR-181a_2, hsa-miR-455, hsa-miR-642, and hsa-miR-4417 expressions in SCLC cell lines, not only in cellular but also in exosomal content.
Conclusions:
Small extracellular vesicles and MYC are essential targets for therapeutic strategy in SCLC. Our study revealed that the expression level of MYC can affect the function of sEVs and encapsulate the miRNA composition in SCLC. Besides, small extracellular vesicles derived from SCLC cells can modulate normal lung cells.
Insights
Small extracellular vesicles (sEVs) from small cell lung cancer (SCLC) cells promote normal lung cell growth and migration. MYC gene expression influences sEV function and miRNA content, suggesting sEVs and MYC as potential SCLC therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- MYC gene amplification/overexpression occurs in 20% of small cell lung cancers (SCLCs).
- Myc and Myc-dependent pathways are potential therapeutic targets in SCLC.
- Small extracellular vesicles (sEVs) are implicated in cancer progression, but their association with Myc in SCLC is unexplored.
Purpose of the Study:
- To investigate the role of Myc in regulating the function and miRNA composition of small extracellular vesicles (sEVs) in small cell lung cancer (SCLC).
- To determine if SCLC-derived sEVs can modulate the behavior of normal lung cells.
Main Methods:
- Small extracellular vesicles (sEVs) were isolated from SCLC cell lines (H82 and H209) with manipulated Myc expression.
- Normal human umbilical vein endothelial cells (HUVECs) and MRC-5 lung fibroblasts were treated with SCLC-derived sEVs.
- Cellular activity (proliferation, migration) of recipient cells was assessed using cell growth, wound healing, and transwell assays.
- miRNA profiling of SCLC cells and their derived sEVs was performed using microarray and qRT-PCR.
Main Results:
- SCLC-derived sEVs significantly increased proliferation and migration of normal lung cells (HUVECs and MRC-5).
- Myc manipulation in SCLC cells altered the miRNA composition of both the cells and their released sEVs.
- Myc was found to regulate the expression of specific miRNAs (hsa-miR-7, hsa-miR-9, hsa-miR-125b, hsa-miR-181a_2, hsa-miR-455, hsa-miR-642, hsa-miR-4417) in SCLC cells and their sEVs.
Conclusions:
- Small extracellular vesicles (sEVs) and MYC are critical targets for SCLC therapeutic strategies.
- MYC expression levels influence the functional properties and miRNA cargo of sEVs in SCLC.
- SCLC-derived sEVs possess the capability to alter the behavior of normal lung cells, highlighting their role in tumor progression.
More Related Videos
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
07:29Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023
Related Concept Videos
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Induced Pluripotent Stem Cells
Somatic...